News
HC Wainwright & Co. Reiterates Buy on Clene, Maintains $7 Price Target
8 May 24
News, Price Target, Reiteration, Analyst Ratings
Clene Q1 EPS $(0.09) Misses $(0.08) Estimate, Sales $73.00K Miss $120.00K Estimate
8 May 24
Earnings, Earnings Misses, News
12 Health Care Stocks Moving In Monday's After-Market Session
6 May 24
Movers
12 Health Care Stocks Moving In Friday's After-Market Session
19 Apr 24
Movers
The Analyst Verdict: Clene In The Eyes Of 5 Experts
17 Apr 24
Analyst Ratings
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
17 Apr 24
Movers
HC Wainwright & Co. Reiterates Buy on Clene, Maintains $7 Price Target
17 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket
17 Apr 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Tuesday's After-Market Session
16 Apr 24
Movers
Clene Highlights Presentation Of Phase 2 VISIONARY-MS Trial Data At 2024 American Academy of Neurology Annual Meeting; Says 'Long-term CNM-Au8 treatment, encompassing up to three years, was well-tolerated; no significant safety findings were observed'
16 Apr 24
Biotech, News, General
Benchmark Reiterates Buy on Clene, Maintains $5 Price Target
20 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Clene Announces Peer-Reviewed Publication Characterizing Protein Corona Of Investigational Neurodegenerative Disease Drug, CNM-Au8
15 Mar 24
Biotech, News, General
Breaking Down Clene: 4 Analysts Share Their Views
13 Mar 24
Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Clene, Maintains $7 Price Target
13 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Clene: Q4 Earnings Insights
13 Mar 24
Earnings
Clene FY GAAP EPS $(0.47) Misses $(0.46) Estimate, Sales $654.00K Beat $557.00K Estimate
13 Mar 24
Earnings, News
HC Wainwright & Co. Maintains Buy on Clene, Maintains $7 Price Target
11 Mar 24
News, Price Target, Analyst Ratings
Clene Presents Clinical Results Of CNM-Au8 30mg Treatment From Visionary-MS Trial Long-Term Extension At Annual ACTRIMS Forum 2024
29 Feb 24
Biotech, News, Events, General
HC Wainwright & Co. Reiterates Buy on Clene, Maintains $7 Price Target
22 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Clene Reports Survival Benefit With CNM-Au8 Treatment In ALS EAP Compassionate Use Programs
22 Feb 24
Biotech, News, General
Press releases
IBN Announces From Lab to Launch Podcast Featuring Clene Inc. CEO Rob Etherington
1 May 24
Press Releases, General
Evidence for Clene's CNM-Au8® as a Treatment for Repair and Remyelination in Multiple Sclerosis Presented in the Emerging Science Session at the 2024 American Academy of Neurology Annual Meeting
16 Apr 24
Health Care, Press Releases, General
IBN Announces First in Human Podcast Featuring Clene Inc. CEO Rob Etherington
19 Mar 24
News, Management, Press Releases
Clene Reports Full Year 2023 Financial Results and Recent Operating Highlights
13 Mar 24
Earnings, Press Releases